SCHEMBL24257038

SCHEMBL24257038

COC(=O)N[C@@H](C)CNc1nccc(-c2sc(C(C)(C)C)nc2-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)n1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.68
HDAC1 Q13547 2/20 0.68
HDAC6 Q9UBN7 2/20 0.68
HDAC3 O15379 1/20 0.68
HDAC7 Q8WUI4 1/20 0.68
HDAC2 Q92769 1/20 0.68
PLK4 O00444 1/20 0.65
EPHB6 O15197 1/20 0.65
RIPK2 O43353 1/20 0.65
JAK2 O60674 1/20 0.65
ULK1 O75385 1/20 0.65
ERN1 O75460 1/20 0.65
NR1I2 O75469 1/20 0.65
PRKD3 O94806 1/20 0.65
ABL1 P00519 1/20 0.65
KRAS P01116 1/20 0.65
RAF1 P04049 1/20 0.65
LCK P06239 1/20 0.65
FYN P06241 1/20 0.65
CDK1 P06493 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257057 0.95 BRAF (0.66) BRAFHDAC1HDAC6HDAC3HDAC7
SCHEMBL30464228 0.95 BRAF (0.66) BRAFHDAC1HDAC6HDAC3HDAC7
SCHEMBL14865884 0.92 BRAF (0.72) BRAFHDAC1HDAC6HDAC3HDAC7
SCHEMBL24257234 0.91 BRAF (0.66) BRAFHDAC1HDAC6HDAC3HDAC7
SCHEMBL24257174 0.91 BRAF (0.70) BRAFHDAC1HDAC6HDAC3HDAC7
SCHEMBL30464230 0.91 BRAF (0.70) BRAFHDAC1HDAC6HDAC3HDAC7
SCHEMBL26338862 0.91 BRAF (0.70) BRAFHDAC1HDAC6HDAC3HDAC7
SCHEMBL26339730 0.90 BRAF (0.62) BRAFHDAC1HDAC6HDAC3HDAC7
SCHEMBL26339025 0.89 BRAF (0.59) BRAFHDAC1HDAC6HDAC3HDAC7
SCHEMBL1127862 0.89 BRAF (0.73) BRAFHDAC1HDAC6HDAC3HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303551-A1 N-CYCLYL-SULFONAMIDES USEFUL FOR INHIBITING RAF ALBERT EINSTEIN COLLEGE OF MEDICINE 2023-09-28 US disclosed
US-20230303551-A1 N-CYCLYL-SULFONAMIDES USEFUL FOR INHIBITING RAF ALBERT EINSTEIN COLLEGE OF MEDICINE 2023-09-28 US disclosed
WO-2022036176-A1 N-CYCLYL-SULFONAMIDES USEFUL FOR INHIBITING RAF ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2022-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303551-A1 N-CYCLYL-SULFONAMIDES USEFUL FOR INHIBITING RAF BRAF, RAF1, NRAS BRAF 1/4885HDAC1 702/4885HDAC6 1332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.